Baxter Web-Enabled Device Development Starting With Renal Dialysis
This article was originally published in The Gray Sheet
Executive Summary
Baxter projects the growth rate of its renal business will accelerate to 15% "over the next several years" from its current growth rate of "10 to 12%" in part due to web-enabled devices under development.